glp-1 vision loss ema recommendation november 2025 Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in review - Topouzis - - British Journal of Pharmacology Ozempic Lawsuit [July 2026 Update]

Managing side effects when you do take it early Even though one-day-early dosing is safe, you might still experience enhanced side effects

After incubation for 1 h at 37 C, two working solutions were added for co-incubation for another 10 min

GLP-1 receptor agonists (GLP-1 RAs), medications that help control type 2 diabetes and obesity, can have a profound impact on physical wellness but what about mental health

Originally developed for type 2 diabetes management, several of these medications have received FDA approval for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with weight-related comorbidities

From an epidemiological perspective, T2DM is a highly prevalent disease worldwide, affecting more than 500 million individuals, with a reported prevalence of approximately 14% among elderly populations in China 2 , 33

Among the most common are nausea, gastrointestinal changes, fatigueand headaches